Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NAD. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel pentamethine precursor method for high-purity NAD analogs. Scalable process reduces hazardous waste and ensures supply continuity for pharma intermediates.
Patent CN102876759A details a chemo-enzymatic NAD preparation method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108675942A reveals nanometer vanadium iron catalyst for aromatic nitriles. Mild conditions, high yield, cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101585763B reveals a high-yield synthesis route for fexofenadine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101585767B reveals a high-yield synthesis for 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropionate, eliminating meta-isomers and reducing environmental impact for reliable supply.
Patent CN101585782B reveals a high-yield synthesis for Fexofenadine intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN101585768B details a high-yield route for 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropanoate. Eliminates meta-isomers for superior supply chain reliability.
Patent CN101987839B details high-purity 2 5-diformylfuran synthesis via vanadium catalysis offering significant supply chain stability and cost reduction benefits.
Patent CN1516689A details a novel route for fexofenadine via regioselective acylation and crystallization, offering cost reduction in pharmaceutical manufacturing.
Novel copper-vanadium catalyst technology improves pretilachlor yield and purity, offering cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Novel vanadium-catalyzed route offers high purity pregabalin. Reduces steps and improves yield for reliable API intermediate supplier.
Advanced vanadium catalysis patent CN106380429A enables high-purity pharmaceutical intermediate manufacturing with reduced waste and optimized supply chain reliability for global buyers.
Patent CN101974603B reveals a novel NAD-independent enzymatic resolution method for high-purity D-alpha-hydroxybutyric acid, offering significant cost reduction and scalable supply chain solutions.
Advanced synthesis of 3-oxo-alpha-ionol offers high purity and yield. Optimized for commercial scale-up and supply chain reliability in fragrance manufacturing.
Patent CN105839134B reveals green electrooxidation for beta-menadione. This method ensures high purity and cost reduction in vitamin K3 manufacturing supply chains.
Patent CN112626547B reveals ultrasonic-assisted indirect electrosynthesis for high-purity quinones, offering significant cost reduction and green manufacturing advantages.
Patent CN102992989A offers chromium-free beta-menadione synthesis. Enhances supply chain reliability and reduces environmental impact for pharmaceutical manufacturers.
Patent CN102249887A details a TS-1 catalyzed oxidation route for Vitamin K intermediates, offering superior selectivity and reduced environmental impact compared to chromium methods.
Novel vanadium catalyst method for heterocyclic amides. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing. Enhances purity and scalability.
Patent CN119613241B introduces iodine-catalyzed photocatalysis for menadione. Offers high yield, continuous flow scalability, and reduced toxic waste for reliable pharmaceutical intermediates supply chains.